[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT06252545":3,"trial-entities:NCT06252545":109,"trial-summary:NCT06252545":113},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":12,"sponsor_name":13,"lead_sponsor_class":14,"has_dmc":15,"brief_summary":16,"detailed_description":17,"conditions":18,"keywords":20,"study_type":24,"primary_purpose":25,"phases":26,"enrollment_info":28,"interventions":31,"primary_outcomes":43,"secondary_outcomes":48,"sex":49,"minimum_age":50,"maximum_age":17,"healthy_volunteers":51,"eligibility_criteria":52,"std_ages":56,"locations":59,"central_contacts":96,"overall_officials":101,"references":104,"see_also_links":105},"NCT06252545","LCCC2234","Promoting CT Engagement for Pancreatic Cancer With App","PROmoting CLinicAl TrIal EngageMent for Pancreatic Cancer App Study (PROCLAIM Study","RECRUITING","2027-02-01","2026-05","2026-05-14","2024-02-02","UNC Lineberger Comprehensive Cancer Center","OTHER",true,"To develop a culturally tailored informational mobile application and test whether it will increase participation among Black pancreatic cancer subjects in clinical trial discussions with their care team.\n\nThis project aims to identify and address barriers to enrollment of Black subjects in pancreatic cancer clinical trials using a culturally informed mobile health application to promote participation.\n\nThe clinical trial education and communication needs of Black people with pancreatic cancer will be determined. A new mHealth application for clinical trial education and communication tailored to subject needs will be developed. It was hypothesized that a culturally tailored informational mobile application will increase the participation of Black subjects in clinical trial discussions with their care team among the target population.\n\nThis study focuses on Black pancreatic cancer subjects, who experience higher mortality rates and lower clinical trial participation than White subjects. Research shows that the disparity between clinical trial participation is in part due to inequitable recruitment practices. This study will use mobile application technology (mHealth app) as an educational, communication, audit, and feedback tool to promote patient-initiated clinical trial discussions among Black people with pancreatic cancer and their cancer care team.",null,[19],"Pancreas Cancer",[21,22,23],"ethnicity","black","application","INTERVENTIONAL","HEALTH_SERVICES_RESEARCH",[27],"NA",{"count":29,"type":30},26,"ESTIMATED",[32,38],{"type":33,"name":34,"description":35,"armGroupLabels":36},"BEHAVIORAL","semistructured interviews","Black subjects with pancreatic cancer will provide insight on their experience discussing clinical trials and preferences for communicating clinical trial information",[37],"Interview Group",{"type":33,"name":39,"description":40,"armGroupLabels":41},"feedback","Black subjects with pancreatic cancer will provide feedback on mHealth app prototype.",[42],"User Testing Group",[44],{"measure":45,"description":46,"timeFrame":47},"The clinical trial education and communication needs","The clinical trial education and communication needs of Black people with pancreatic cancer will be determined with feedback and qualitative analysis of findings from semi-structured interviews to develop an mHealth application.","Up to 1 month",[],"ALL","18 Years",false,{"inclusion":53,"exclusion":54,"raw_text":55},[],[],"Inclusion Criteria\n\nParticipants must meet the following inclusion criteria in order to participate in communication \\& education interview component of the study:\n\n1. Informed consent obtained to participate in the study\n2. 18 years or older\n3. English speaking\n4. Able and willing to participate in a 1-hour interview\n5. History of pancreatic cancer diagnosis\n6. Identify as Black\n\nExclusion Criteria:\n\nAll participants meeting any of the following exclusion criteria will be excluded from the study:\n\n1. Inability to read and speak English\n2. Dementia altered mental status, or any psychiatric condition that would prohibit understanding or rendering of informed consent as determined by the study physician.",[57,58],"ADULT","OLDER_ADULT",[60,81],{"facility":13,"status":8,"city":61,"state":62,"zip":63,"country":64,"contacts":65,"geoPoint":78},"Chapel Hill","North Carolina","27599","United States",[66,71,75],{"name":67,"role":68,"phone":69,"email":70},"Lori Stravers","CONTACT","919-966-4432","lori_stravers@med.unc.edu",{"name":72,"role":68,"phone":73,"email":74},"Maddy Ledenyi","+1 919-843-4699","Madeleine_Ledenyi@med.unc.edu",{"name":76,"role":77},"Jen Jen Yeh, MD","PRINCIPAL_INVESTIGATOR",{"lat":79,"lon":80},35.9132,-79.05584,{"facility":82,"status":8,"city":83,"state":84,"zip":85,"country":64,"contacts":86,"geoPoint":93},"Medical College Of Wisconsin","Milwaukee","Wisconsin","53226",[87,91],{"name":88,"role":68,"phone":89,"email":90},"Christian Campbell","+1 414-955-1423","ccampbell@mcw.edu",{"name":92,"role":77},"Ugwuji Maduekwe, MD, MMSc, MPH",{"lat":94,"lon":95},43.0389,-87.90647,[97,99],{"name":67,"role":68,"phone":98,"email":70},"1 919-966-4432",{"name":72,"role":68,"phone":100,"email":74},"(919) 843-4699",[102],{"name":103,"affiliation":13,"role":77},"Jen J Yeh, MD",[],[106],{"label":107,"url":108},"University of North Carolina Lineberger Comprehensive Cancer Center Clinical Trials","http:\u002F\u002Funclineberger.org\u002Fpatientcare\u002Fclinical-trials\u002Fclinical-trials",{"nct_id":4,"conditions":110,"biomarkers":112},[111],"Pancreatic Carcinoma",[],{"nct_id":4,"found":15,"summary":114,"prompt_version":124},{"design":115,"status":116,"heading":117,"summary":118,"follow_up":119,"word_count":120,"commitments":121,"compensation":122,"drugs_mentioned":123},"This study plans to enroll 26 participants. It is an interventional study, meaning participants will engage in specific activities.","completed","Understanding Communication Needs for Pancreatic Cancer Clinical Trials","This study aims to understand how to best share information about clinical trials with Black individuals who have pancreatic cancer. Researchers will conduct interviews to learn about your experiences discussing clinical trials and your preferences for receiving information. You will also have the opportunity to provide feedback on a mobile app designed to help with this. The goal is to develop a helpful app that encourages more Black individuals with pancreatic cancer to talk with their care team about clinical trials. To join, you must be 18 or older, speak English, and have a history of pancreatic cancer. The study is currently unclear on its recruitment status.","The primary endpoint, focusing on education and communication needs, will be measured for up to 1 month.",107,"You would participate in a 1-hour interview. You would also provide feedback on a mobile health app prototype.","Not stated in the trial record.",[39],"v2"]